Osaic Holdings’s Disc Medicine IRON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.6K Sell
268
-7
-3% -$481 ﹤0.01% 6185
2026
Q1
$17.6K Buy
275
+2
+0.7% +$139 ﹤0.01% 5937
2025
Q4
$21.7K Buy
273
+3
+1% +$253 ﹤0.01% 5833
2025
Q3
$17.8K Hold
270
﹤0.01% 6008
2025
Q2
$14.3K Buy
+270
New +$12.7K ﹤0.01% 5949
2025
Q1
Sell
-417
Closed -$26.4K 7583
2024
Q4
$26.4K Buy
+417
New +$24.1K ﹤0.01% 5147
2024
Q3
Sell
-223
Closed -$10.1K 7482
2024
Q2
$10.1K Buy
+223
New +$7.58K ﹤0.01% 5784
2023
Q3
Sell
-1
Closed -$44 7459
2023
Q2
$44 Buy
+1
New +$35 ﹤0.01% 7334

Other funds holding IRON

Osaic Holdings's IRON Position: Q2 2026 in Review

Osaic Holdings reduced its Disc Medicine (IRON) stake by 2.5% in Q2 2026, selling an estimated $481 and leaving 268 shares worth $19.6K. The position accounts for ﹤0.01% of the portfolio, ranked #6185.

Osaic Holdings first reported a position in IRON in Q2 2023 and has held it in 8 quarters since. The position peaked at $26.4K in Q4 2024. 215 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Osaic Holdings held 268 shares of Disc Medicine worth $19.6K as of Q2 2026.
  • Osaic Holdings sold 7 Disc Medicine shares in Q2 2026, an estimated $481.
  • Disc Medicine made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #6185 holding.
  • Osaic Holdings first reported a position in Disc Medicine in Q2 2023 and has held it in 8 quarters since.
  • Osaic Holdings's Disc Medicine position peaked at $26.4K in Q4 2024.
  • 215 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.